Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Stéphanie Hambye"'
Uncovering the antimalarial potential of toad venoms through a bioassay-guided fractionation process
Publikováno v:
International Journal for Parasitology: Drugs and Drug Resistance, Vol 20, Iss , Pp 97-107 (2022)
Malaria remains to date one of the most devastating parasitic diseases worldwide. The fight against this disease is rendered more difficult by the emergence and spread of drug-resistant strains. The need for new therapeutic candidates is now greater
Externí odkaz:
https://doaj.org/article/64d4a6bd3cc14416a1c0e1f8cc3f85d7
Autor:
Alexandra Baroni, Ioan Neaga, Nicolas Delbosc, Mathilde Wells, Laetitia Verdy, Eugénie Ansseau, Jean Jacques Vanden Eynde, Alexandra Belayew, Ede Bodoki, Radu Oprean, Stéphanie Hambye, Bertrand Blankert
Publikováno v:
ACS Omega, Vol 4, Iss 19, Pp 18126-18135 (2019)
Externí odkaz:
https://doaj.org/article/3d9c9b6189f84170881715403bba9729
Autor:
Laura Soumoy, Mathilde Wells, Ahmad Najem, Mohammad Krayem, Ghanem Ghanem, Stéphanie Hambye, Sven Saussez, Bertrand Blankert, Fabrice Journe
Publikováno v:
Biology, Vol 9, Iss 8, p 218 (2020)
Melanoma is the most common cancer in young adults, with a constantly increasing incidence. Metastatic melanoma is a very aggressive cancer with a 5-year survival rate of about 22−25%. This is, in most cases, due to a lack of therapies which are ef
Externí odkaz:
https://doaj.org/article/2bae868e5a414922aeb9ba518329c47e
Autor:
Ruddy Wattiez, Bertrand Blankert, Mathilde Wells, Médéric Loyez, Christophe Caucheteur, François Hubinon, Stéphanie Hambye
Publikováno v:
Malaria Journal, Vol 20, Iss 1, Pp 1-9 (2021)
Malaria Journal
Malaria Journal
Background Early malaria diagnosis and its profiling require the development of new sensing platforms enabling rapid and early analysis of parasites in blood or saliva, aside the widespread rapid diagnostic tests (RDTs). Methods This study shows the
Publikováno v:
Toxicon. 227:107092
Autor:
Jean Jacques Vanden Eynde, Radu Oprean, Mathilde Wells, Ioan-Ovidiu Neaga, Alexandra Belayew, Bertrand Blankert, Nicolas Delbosc, Laetitia Verdy, Eugénie Ansseau, Ede Bodoki, Alexandra Baroni, Stéphanie Hambye
Publikováno v:
ACS Omega
ACS Omega, Vol 4, Iss 19, Pp 18126-18135 (2019)
ACS Omega, Vol 4, Iss 19, Pp 18126-18135 (2019)
Dystrophia myotonica type 1 (DM1) results from nuclear sequestration of splicing factors by a messenger RNA (mRNA) harboring a large (CUG)n repeat array transcribed from the causal (CTG)n DNA amplification. Several compounds were previously shown to
Publikováno v:
Journal of Separation Science. 42:1384-1392
Marinobufagenin is a bufadienolide compound detected mainly in skin and parotoid gland secretions of Rhinella marina (L.) toad. Bufadienolides regulate the Na+ /K+ -ATPase pump by inhibiting the cardiotonic steroid dependent-site and act as cardiac i
Autor:
Fabrice Journe, Mathilde Wells, Bertrand Blankert, Ghanem Elias Ghanem, Sven Saussez, Ahmad Najem, Stéphanie Hambye, Mohammad Krayem, Laura Soumoy
Publikováno v:
Biology
Volume 9
Issue 8
Biology, 9 (8
Biology, Vol 9, Iss 218, p 218 (2020)
Volume 9
Issue 8
Biology, 9 (8
Biology, Vol 9, Iss 218, p 218 (2020)
Melanoma is the most common cancer in young adults, with a constantly increasing incidence. Metastatic melanoma is a very aggressive cancer with a 5-year survival rate of about 22−25%. This is, in most cases, due to a lack of therapies which are ef
Autor:
Alexandra Belayew, Jean Jacques Vanden Eynde, Bertrand Blankert, Claudio Palmieri, Ede Bodoki, Ioan-Ovidiu Neaga, Stéphanie Hambye, Radu Oprean, Eugénie Ansseau
Publikováno v:
Analytical and bioanalytical chemistry. 411(2)
Unfortunately the name of Jean Jacques Vanden Eynde was missing as co-author of this contribution. The correct list of authors is: Ioan O. Neaga, Stephanie Hambye, Ede Bodoki, Claudio Palmieri, Jean Jacques Vanden Eynde, Eugenie Ansseau, Alexandra Be
Autor:
Alexandra Belayew, Eugénie Ansseau, Claudio Palmieri, Ede Bodoki, Stéphanie Hambye, Ioan-Ovidiu Neaga, Bertrand Blankert, Radu Oprean
Publikováno v:
Analytical and bioanalytical chemistry. 410(18)
Myotonic dystrophy type 1 (DM1) is an autosomal dominantly inherited degenerative disease with a slow progression. At the present, there is no commercially available treatment, but sustained effort is currently undertaken for the development of a pro